AVITA Medical (RCEL) EBIT Margin Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn | -19,782.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19,782.00 |
| Sep 30, 2025 | 1,754.00 |
| Jun 30, 2025 | 4,230.00 |
| Mar 31, 2025 | 9,107.00 |
| Dec 31, 2024 | 27,296.00 |
| Sep 30, 2024 | -299.00 |
| Jun 30, 2024 | -783.00 |
| Mar 31, 2024 | -6,101.00 |
| Dec 31, 2023 | -25,574.00 |
| Sep 30, 2023 | -498.00 |
| Mar 31, 2023 | 3,190.00 |
| Sep 30, 2022 | 2,152.00 |
| Mar 31, 2022 | -5,749.00 |
| Sep 30, 2021 | 11,711.00 |
| Jun 30, 2021 | 29,025.00 |
| Mar 31, 2021 | 32,902.00 |
| Dec 31, 2020 | -93,929.00 |
| Sep 30, 2020 | -8,930.00 |
| Jun 30, 2020 | -3,077.00 |
| Mar 31, 2020 | -678.00 |
| Dec 31, 2019 | 143,471.00 |
| Sep 30, 2019 | 176,774.00 |